Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice.
about
Theiler's virus infection: a model for multiple sclerosisA natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunityATP suppression of interleukin-12 and tumour necrosis factor-alpha release from macrophagesDecreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritisThe Mucosal Immune System and Its Regulation by AutophagyGenetics of type 1 diabetes mellitusAmelioration of type 1 diabetes following treatment of non-obese diabetic mice with INGAP and lisofylline.Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium.The toxicology of interleukin-12: a review.Dissecting the role of CD4+ T cells in autoimmune diabetes through the use of TCR transgenic mice.IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responsesCytokine regulation of a rodent model of mercuric chloride-induced autoimmunityPrevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetopeActivation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets.IL-1β promotes TGF-β1 and IL-2 dependent Foxp3 expression in regulatory T cells.Enhanced Th1 and dampened Th2 responses synergize to inhibit acute granulomatous and fibrotic responses in murine schistosomiasis mansoni.Polarization of the immune response to the single immunodominant epitope of p38, a major Schistosoma mansoni egg antigen, generates Th1- or Th2-type cytokines and granulomas.Selective immunointervention in autoimmune diseases: lessons from multiple sclerosis.T-cell tolerance and autoimmune diabetes.Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cellsRegulation of lipopolysaccharide-induced interleukin-12 production by activation of repressor element GA-12 through hyperactivation of the ERK pathwayNOD dendritic cells stimulated with Lactobacilli preferentially produce IL-10 versus IL-12 and decrease diabetes incidenceCytokine-based immunointervention in the treatment of autoimmune diseases.Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity.Hydrogen-bonded multilayers of tannic acid as mediators of T-cell immunity.Serum interleukin 12 concentration in juvenile chronic arthritisInterleukin-12 is critical for induction of nitric oxide-mediated immunosuppression following vaccination of mice with attenuated Salmonella typhimurium.Histidine Decarboxylase Deficiency Prevents Autoimmune Diabetes in NOD Mice.Interleukin-12-induced adhesion molecule expression in murine liverInterleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis.Interleukin-12 (IL-12)/STAT4 Axis Is an Important Element for β-Cell Dysfunction Induced by Inflammatory Cytokines.Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells.Beta cell apoptosis in T cell-mediated autoimmune diabetes.Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.Anti-IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function.Constitutive beta cell expression of IL-12 does not perturb self-tolerance but intensifies established autoimmune diabetes.Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice.Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetesDendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant.The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
P2860
Q24629115-2BB67AC0-B782-4A80-8EB7-6F1E996AC630Q24673016-E5A1CE38-ABA5-4ABA-94C8-EC6F87AB323BQ24675140-1691A345-B154-47BC-B044-148134213010Q24792962-DE8A74B8-BD55-4EA2-B95B-65ED23EB3FEAQ26742170-E5E1D20A-2B50-4713-9F57-52628EB41E9AQ28215982-81FEA1E4-4AA6-4B1D-9A37-D67CFC99540AQ30370459-D7A68D2F-52CE-4C62-AE9E-06AA81B58E63Q33517087-D953131E-CA32-43F3-9FF6-30B485D192E3Q33657643-FD4740C5-2C4A-4728-AC83-E068B8FD50C6Q33713280-7C4C81F9-6F96-47A3-9349-C3E285400DBCQ33716470-A77005EF-8B41-4947-BDB7-CC38E6DEEBC0Q33741231-43C13AD9-A677-4949-9A48-1E44A91FFA06Q33937758-2D62B675-D0FC-4C79-A7AD-EB02D5D69B4AQ33950117-537A8583-5076-400F-9112-9B6E3F266906Q33968156-79772227-2604-4835-B617-EECDFA7A796EQ34000581-3A8B22BC-1FCC-4307-BE33-4FF92907A90FQ34001745-5C712055-EC01-4BBC-B8B6-D3CFC673E8A6Q34307160-49AE5574-E8AB-4A7B-ADAE-D75EADC842EEQ34552317-93483A5C-6B5B-47BA-BDD0-3C95C866D5CDQ34734082-2A920FD1-4F15-476C-B0BB-0AD2519E1121Q34975081-C7A2A650-AF51-4F84-ACAA-FC1D248519D1Q35058089-EE6A5575-4BB9-4BB8-84E9-1079741BA0BEQ35109131-E2CCF63E-8F55-4823-A37E-F8D57C06FAFDQ35294492-48EFEB6E-A40E-4820-8CB4-EB2331B33710Q35328778-66D06D18-56D7-4C30-A6E6-9B63F1373FBAQ35547995-B443F4C3-70A3-4AAF-9772-C623BCCEF6F2Q35559415-6627DC32-0215-4A91-BC05-1B866A56E118Q35674253-C89BBFFA-B5A8-4D3E-930A-FB20C7AB59CCQ35763756-ACC1691B-7E61-459F-9356-F8187A5AF89FQ35765389-1116247A-D5C3-4FCB-91FD-CAAA8F086888Q35837421-B1A93F0F-80BE-484E-8E3E-020D1CF6267FQ35901700-E8FFAFBC-ABF3-45B5-9637-223B70F6E052Q35905815-357BB18A-944B-4DBA-B876-67AC706A23ADQ35957193-408F542B-1B04-419E-A4DA-5472C0274D48Q36140610-BF701DD0-1041-42E4-A40E-1805E1A4981EQ36170029-2FD2F022-EF63-4D5D-93B2-956C81603F43Q36179395-26BCE29B-3EED-450E-8B1C-40D09B6D3552Q36364761-A8A1A8C4-B250-4830-9487-EACE3D1D02CAQ36365918-785C0444-D8C8-4A5B-9209-1D6958FBBD69Q36366549-7CBB6D6C-89B6-4780-B3D7-DCC00592F2BB
P2860
Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Interleukin 12 administration ...... toimmune diabetes in NOD mice.
@ast
Interleukin 12 administration ...... toimmune diabetes in NOD mice.
@en
type
label
Interleukin 12 administration ...... toimmune diabetes in NOD mice.
@ast
Interleukin 12 administration ...... toimmune diabetes in NOD mice.
@en
prefLabel
Interleukin 12 administration ...... toimmune diabetes in NOD mice.
@ast
Interleukin 12 administration ...... toimmune diabetes in NOD mice.
@en
P2093
P2860
P356
P1476
Interleukin 12 administration ...... toimmune diabetes in NOD mice.
@en
P2093
P2860
P304
P356
10.1084/JEM.181.2.817
P407
P577
1995-02-01T00:00:00Z